
Maruti Suzuki Q1 Results: Weak quarter expected as margins may hit multi-quarter lows
Maruti Suzuki is expected to report a weak Q1, with low single-digit revenue growth and margins at multi-quarter lows.

Maruti Suzuki is expected to report a weak Q1, with low single-digit revenue growth and margins at multi-quarter lows.

Earlier in the month, the company bagged an export order worth ₹105 crore for the manufacture and supply of defence explosives to international clients.

In India, gold prices followed global cues and got an extra push from a weaker rupee. According to Goodreturns, the price of 24-karat gold is…

The local currency had tumbled 89 paise on Wednesday (July 30), logging its sharpest single-day drop in over three years.

The company announced the acquisition of 100% global ownership of its novel antibiotic Enmetazobactam, which was originally discovered and developed in-house.

India currently holds about 20% of the global shrimp market share, with production expected to remain flat at 1.2 million metric tonnes this fiscal, according…

On Thursday, market tech analyst Mitessh Thakkar recommended these stocks for the short term.

The development has raised concerns around Indian auto companies, particularly those with exposure to US markets.

Q1 Results LIVE Updates: HUL, Sun Pharma, Maruti Suzuki India, Adani Enterprises, Coal India, Vedanta, Ambuja Cements, Eicher Motors, TVS Motor Company Mankind Pharma, Dabur…

HUL’s EBITDA margins for the quarter contracted by 120 basis points to 22.3% from 23.5% last year, while the CNBC-TV18 poll had projected a 100…